Resolute Science: Funding, Investors & Team (Sep 2026)
Resolute is creating a new class of medicines for aggressive solid tumors that are uncommon and challenging to treat. Founded with the goal of curing solid tumors, Resolute uses the technology platform of MAC-TACs (Macrophage Targeted Conjugates) to develop a wide range of biomarker-driven, first-in-class, synthetic molecules that are potentially safer and more effective than current standard of care for pan-cancer patients.
Resolute Science has raised $2.1M across 2 funding rounds on record, the most recent an undisclosed round announced in Feb 2025.
Resolute Science Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Resolute Science Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Resolute Science raised $2.1M in an undisclosed round announced in Jul 2024.
7 months later, an undisclosed round was announced in Feb 2025 with no disclosed amount.
Resolute Science Founders and Leadership Team
Contact details for the Resolute Science team: 1 of 1 has an email address on file.
Start 14-day free trial →Resolute Science Funding Compared to Other Biotechnology Startups
Funded Startups Like Resolute Science in Biotechnology and San Diego
Companies Similar to Resolute Science
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Resolute Science Funding FAQs
What does Resolute Science do?
Resolute is creating a new class of medicines for aggressive solid tumors that are uncommon and challenging to treat. Founded with the goal of curing solid tumors, Resolute uses the technology platform of MAC-TACs (Macrophage Targeted Conjugates) to develop a wide range of biomarker-driven, first-in-class, synthetic molecules that are potentially safer and more effective than current standard of care for pan-cancer patients.
How much funding has Resolute Science raised?
Resolute Science has raised $2.1M across 2 rounds on record.
When did Resolute Science last raise funding?
Resolute Science's most recent funding round on record was announced in Feb 2025. The amount was not disclosed.
Who founded Resolute Science?
FundedIQ lists Faith H Barnett (Founder) at Resolute Science.
Where is Resolute Science headquartered?
Resolute Science is based in San Diego, California, United States.
How many employees does Resolute Science have?
Resolute Science is in the 1-10 employee band.
About FundedIQ's Resolute Science Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Resolute Science is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.